{
    "name": "netarsudil ophthalmic",
    "comment": "Rx",
    "other_names": [
        "Rhopressa"
    ],
    "classes": [
        "Ophthalmics",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/rhopressa-netarsudil-1000159",
    "pregnancy": {
        "common": [
            "Data are not available on use in pregnant women to inform of any drug associated risk; however, systemic exposure to netarsudil from ocular administration is low",
            "IV administration of netarsudil to pregnant rats and rabbits during organogenesis did not produce adverse embryofetal effects at clinically relevant systemic exposures"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "No data on the presence in human milk, the effects on the breastfed infant, or the effects on milk production",
            "Systemic exposure to netarsudil following topical ocular administration is low, and unknown whether measurable levels of netarsudil would be present in maternal milk following topical ocular administration"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Bacterial keratitis associated with use of multiple-dose containers of topical ophthalmic products; containers had been inadvertently contaminated by patients who had a concurrent corneal disease or a disruption of the ocular epithelial surface",
                "Remove contact lenses prior to instilling ophthalmic solution; may reinsert lenses 15 minutes following administration",
                "Instruct patients to avoid allowing tip of dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution; serious damage to the eye and subsequent loss of vision may result from using contaminated solutions",
                "Advise patients that if they develop an intercurrent ocular condition (eg, trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, they should immediately seek their physicianâ€™s advice concerning continued use of this drug"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Corneal verticillata",
            "percent": null
        },
        {
            "name": "Instillation site pain",
            "percent": null
        },
        {
            "name": "Conjunctival hemorrhage",
            "percent": null
        },
        {
            "name": "Instillation site erythema",
            "percent": null
        },
        {
            "name": "Corneal staining",
            "percent": null
        },
        {
            "name": "Blurred vision",
            "percent": null
        },
        {
            "name": "Increased lacrimation",
            "percent": null
        },
        {
            "name": "Erythema of eyelid",
            "percent": null
        },
        {
            "name": "Reduced visual acuity",
            "percent": null
        }
    ]
}